THNR
Amplify Weight Loss Drug & Treatment ETF · PSE
- Category Equity
- Expense Ratio 0.59%
- Listing Date May 21, 2024
- Volume 2,369.0
- Market Cap (AUM) $4.31M
Performance
-3.71%
1W
+5.96%
1M
+4.88%
3M
+6.47%
6M
+6.47%
YTD
+6.47%
1Y
Top Holdings
Recent News & Updates
- 2024-09-04 00:26
3 ETFs to stabilize a portfolio amid volatility: Amplify CEO(Yahoo Finance)
- 2024-06-04 19:00
- 2024-05-20 19:00
Page 1 of 1
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.